Rule 425 under the Securities Act of 1933 . Soaring Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry E. Sloan, Jeff ⦠The business combination is expected to be completed in the first half of 2021. This Forward Purchase Agreement (this âAgreementâ) is entered into as of [â¢], 2021, by and between Soaring Eagle Acquisition Corp., a Cayman Islands exempted company (the âCompanyâ), and [â¢], a [â¢] (the âPurchaserâ). Soaring Eagle Acquisition Acquisition Corp ... SoftBank is leading a $1.5B PIPE and Novator Capital has committed to backstop any redemptions. This is the second business combination for Gingko Bioworks in as many weeks. Soaring Eagle Acquisition Acquisition Corp (SRNG) has struck a $15B SPAC deal to take cell programming company Ginkgo Bioworks public. Units start trading today on the Nasdaq under SRNGU. Soaring Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry E. Sloan, Jeff Sagansky, and Eli Baker for the purpose of effecting a ⦠The PIPE on the SPAC includes investments from Baillie Gifford, Cascade Investment (Bill Gates) and Ark Investment Management. Soaring Eagle Acquisition Corp. (the "Company"), the seventh public acquisition vehicle led by Eagle Equity Partnersâ Harry Sloan, Jeff Sagansky and ⦠After the deal with this blank check company, the ticker is expected to change to PTRA. ACTC has PIPE backing by the SPAC King, Chamath Palihapitiya. While most of that comes from Soaring Eagle's coffers, about a third has been raised via a $775 million private investment in public equity (PIPE) deal from a range of new and existing investors. Ginkgo Bioworks this morning announced that it will be going public via the SPAC route with that of Soaring Eagle Acquisition Corp (NASDAQ: SRNG). February 24, 2021. Gross proceeds include Soaring Eagleâs US$1.73 billion of cash in trust (subject to any redemptions by Soaring Eagleâs public shareholders) and US$775 million in proceeds from a PIPE transaction priced at US$10 per share of Class A common stock of Soaring Eagle to be funded immediately prior to the closing of the transaction. DraftKings Inc (NASDAQ: DKNG) was one of three companies named as official sports betting partners of the NFL. Soaring Eagle Acquisition (NASDAQ: SRNG) +2% premarket on confirming a deal announced earlier to take Ginko Bioworks public at a $15B pre-money equity valuation and is ⦠Soaring Eagle Acquisition Corp. (NASDAQ:SRNG) is set to merge with bio tech company Ginkgo Bioworks in a $15 Billion deal.The mammoth deal is expected to provide the biotech company $2.5 Billion in primary cash proceeds to fund future growth within multiple industries. MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market. The deal values Ginkgo at $15bn and includes a $775m PIPE financing co-led by Baillie Gifford, Putnam Investments and Morgan Stanley Investment Managementâs Counterpoint Global. and deemed filed pursuant to Rule 14a-12. Entry into a Material Definitive Agreement. Exhibit 10.9 . Last week, the company went public on the Nasdaq Market via a SPAC acquisition by Soaring Eagle Acquisition Corp. On May 11, 2021, Soaring Eagle Acquisition Corp., a Cayman Islands exempted company limited by shares ("SRNG" or the "Company"), entered into an agreement and plan of merger by and among SRNG, SEAC Merger Sub Inc., a wholly owned subsidiary of SRNG ("Merger Sub"), and Ginkgo Bioworks, Inc. ("Ginkgo") (as it may be amended, restated, supplemented or otherwise ⦠BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/ â Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. Soaring Eagle intends to change its name to Ginkgo Bioworks Holdings, Inc. Soaring Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry E. Sloan, Jeff Sagansky, and Eli Baker for the purpose of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. A corporate deal team advises on the transaction that will make Ginkgo Bioworks a publicly traded company. BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/ --. The transaction valued Gingko at a $15 billion pre-money equity valuation, in a deal expected to provide up to $2.5 billion in primary proceeds. Rule 425 under the Securities Act of 1933 . Is Ginkgo the AWS of synthetic biology? The eToro deal will also include a $650 million PIPE so the trust size does not matter as much in this case. PlusAI Corp. Investors will be ⦠It's the 7th SPAC deal for the Eagle Equity team of DraftKings (DKNG) - Get Report fame (among others). Boston-based biotech company Ginkgo Bioworks will make its market debut by merging with Soaring Eagle Acquisition Corp., the blank-check company led by former MGM CEO Harry Sloan.. Ginkgo was started in 2009 by a team of MIT scientists intent on building made-to-order microbes that enable customers to grow rather than manufacture better products. Ginkgo Bioworks, a biotech company based in Boston, announced that it will go public via a merger with Soaring Eagle Acquisition Corp. (SRNG), a special purpose acquisition vehicle (SPAC), in a deal that gives the company a pre-money equity valuation of $15 billion. Item 1.01. The transaction requires the approval of the stockholders of both Soaring Eagle and Ginkgoâs, along with certain regulatory approvals. 1) Aurora Acquisition Corp. (AURC) & Better. Ginkgo Bioworks, a US-based microbe engineering services spinout of MIT, agreed to a reverse merger with SPAC Soaring Eagle Acquisition Corp. Ginkgo Bioworks, a US-based microbe engineering services provider that counts genomics technology producer Illumina as a backer, announced a reverse merger with special purpose acquisition company Soaring Eagle Acquisition Corp. This includes Soaring Eagle Acquisitionâs cash in trust of $1.725 billion, subject to any redemptions by its public shareholders, and $775 million in proceeds from a PIPE transaction. Gross proceeds include Ginkgo Bioworks, a US-based microbe engineering services provider that counts genomics technology producer Illumina as an investor, agreed to a reverse merger with special purpose acquisition company Soaring Eagle Acquisition Corp today. Soaring Eagle units are trading at less than 5% above redemption value, creating a favorable entry point for investors. A $1.5 billion war chest gives Soaring Eagle the ability to combine with an attractive, high-profile target. The transaction implies a pre-money equity valuation for Ginkgo of $15.0 billion, and is expected to provide up to $2.5 billion of gross cash proceeds. Private Equity Soaring Eagle Acquisition Corp. Vice Media Group Better TPG Cathie Wood Ginkgo Bioworks Ark Investment Management Autonomous Vehicles Colonial Pipeline Harry ⦠1 minute read. MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market. Soaring Eagle sought counsel from White & Case. The PIPE on the SPAC includes investments from Baillie Gifford, Cascade Investment (Bill Gates) and Ark Investment Management. Advertisements. And the Bill Gates-backed biotech Ginkgo Bioworks has agreed to go public in a $17.5 billion merger with blank-check firm Soaring Eagle Acquisition Corp. Soaring Eagle Acquisition Units SRNGU Soaring Eagle Acquisition Corp Units gets a top spot due to a strong pedigree. Soaring Eagle units are trading at less than a 5% premium to redemption value, which seems like an outlier for such an experienced and well-known sponsor. $6.73B EV. The arrangement entered into by Ginkgoâs values the company at a $15 billion pre-money valuation, with the go-public event expected to provide the company with $2.5 billion in proceeds. WHEREAS, the Company was incorporated for the purpose of effecting a merger, share exchange, ⦠: 001-40097 A Ropes & Gray team guided Baillie Gifford, a leading asset manager, in connection with a private placement in Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), a special purpose acquisition company that has entered into a business combination transaction with Ginkgo Bioworks, Inc. that will result Ginkgo Bioworks, Inc. becoming a publicly-listed company. The deal includes a $775 million oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds ⦠The Boston-based biotech is set to combine with Nasdaq-listed Soaring Eagle Acquisition Corp, with the merger expected to provide up to $2.5 billion in cash proceeds. Gross proceeds include Soaring Eagleâs $1.725 billion of cash in trust (subject to any redemptions by Soaring Eagleâs public shareholders) and $775 million in proceeds from a ⦠Soaring Eagle Acquisition Corp last traded at $9.92, down 0.20% on this mornings news. It was another busy week for the SPAC market with numerous deal announcements and rumored deals. Additional Information and Where to Find It under the Securities Exchange Act of 1934 . These units entitle a holder to one share and one-fifth of ⦠Pending shareholder approval, upon closing the combined company will be named IronNet Cybersecurity and will list on the NYSE under IRNT. The SPAC comes from Harry Sloan and Jeff Sagansky, the same team that took DraftKings Inc and Skillz Inc (NYSE: SKLZ ) public. Soaring Eagle Acquisition, the seventh SPAC led by Eagle Equity Partners, priced its IPO of 150 million units at $10. 11 May 2021 Ginkgo Bioworks, Inc. and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), a publicly traded special purpose acquisition company, have agreed to a business combination that will result in Ginkgo becoming a publicly traded company. Flying Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry Sloan, Jeff Sagansky, and Eli Baker. Soaring Eagle Acquisition Corp. (the "Company"), the seventh public acquisition vehicle led by Eagle Equity Partnersâ Harry Sloan, Jeff Sagansky and ⦠Ginkgo Bioworks and Soaring Eagle Acquisition today announced a business combination that values the engineered biology company at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. and deemed filed pursuant to Rule 14a-12. The Company provides airlines with in-flight video content, e-commerce, and information services. Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and ⦠Notable IPOâs: 1) Soaring Eagle Acquisition Corp. (SRNG.U) â will trade tomorrow. Investors ⦠NEW YORK, NY April 15, 2021 â Soaring Eagle Acquisition Corp. (the âCompanyâ), the seventh public acquisition vehicle led by Eagle Equity Partnersâ Harry Sloan, Jeff Sagansky and Eli Baker today announced that holders of the units sold in the Companyâs initial public offering of 172,500,000 units completed on February 26, 2021 under the Securities Exchange Act of 1934 . Assuming no redemptions by LGLâs existing ⦠On May 11, 2021, Soaring Eagle Acquisition Corp., a Cayman Islands exempted company limited by shares (âSRNGâ or the âCompanyâ), entered into an agreement and plan of merger by and among SRNG, SEAC Merger Sub Inc., a wholly owned subsidiary of SRNG (âMerger Subâ), and Ginkgo Bioworks, Inc. ⦠Soaring Eagle Acquisition Corp. is the latest SPAC from the team that delivered two of the most successful SPAC business combinations to date - DraftKings and Skillz. SRNGU currently has no news. SRNGU announced Q4 earnings. Soaring Eagle Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Spinning Eagle⦠In this video, I share my bull case, bear case, and 5-year price target for Ginkgo Bioworks stock. * Soaring Eagle Acquisition Corp (SRNG) - INSTITUTIONAL INVESTORS HAVE COMMITTED $775 MILLION IN AN OVERSUBSCRIBED PIPE. Investors will be able to buy common shares and warrants beginning next week. $1.5B, 1/5 warrant SoftBank-backed mortgage startup Better.com is going public via a SPAC merger with Aurora Acquisition Corp. in ⦠Soaring Eagle Acquisition Corp (NASDAQ: SRNGU), which is in talks to take Ginkgo Bioworks public, will split its units on Monday April 19. DIS CL AIMER Disclaimer This confidential presentation (the âpresentationâ) is being delivered to you by Soaring Eagle Acquisition Corp. (âSRNGâ) and Ginkgo Bioworks, Inc. (âGinkgoâ) for use by Ginkgo and SRNG in connection with their proposed business combination and the offering of the securities of the post-business combination company in a private placement (the âTransactionâ). Recitals . The agreement sees Boston, Massachusetts-based Ginkgo Bioworks merging with Soaring Eagle Acquisition Corp. and becoming a single, publicly traded entity, according to a statement. Find out why Iâm bullish on Ginkgo Bioworks stock! IronNet Cybersecurity announced today that it has signed a definitive business combination agreement with LGL Systems Acquisition that would value the merged company at $927 million. Harry Sloanâs seventh SPAC Formation, Soaring Eagle Acquisition Corp is brought by Skillz and Draftkings who are also the executives of blank check company. With the merger, Gingko will go public with $2.5bn in cash proceeds, consisting of $1.7bn from Soaring Eagle Acquisition Corp. and a $775mn PIPE round committed by investors such as Cathie Wood's Ark Invest and Counterpoint Global, an offshoot of Morgan Stanley. Soaring Eagle Acquisition Corp is a SPAC from Harry Sloan and Jeff Sagansky, a seasoned SPAC team that previously brought DraftKings Inc (NASDAQ: DKNG) and Skillz (NYSE: SKLZ) public.. $ Volume: $1500.0 mil: Manager / Joint Managers: Goldman Sachs: CO-Managers-Expected To Trade: 2/24/2021 This includes Soaring Eagle Acquisitionâs cash in trust of $1.725 billion, subject to any redemptions by its public shareholders, and $775 million in proceeds from a PIPE transaction. Published on May 11, 2021 Ginkgo Bioworks, a Boston, MA-based platform to program cells, and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), a ⦠As traditional farming gets less sustainable, vertical farming is filling in the gaps. Among the PIPE participants are lead investors Baillie Gifford, Putnam Investments, and Morgan Stanleyâs Counterpoint Global. Adam Natan is an associate in Ropes & Grayâs mergers and acquisitions group. SPACs Attack Recap: 5 Deals, Rumors And Headline News. Soaring Eagle Acquisition Corp (SRNG): * GINKGO BIOWORKS TO BECOME A PUBLIC COMPANY AND EXPAND ITS LEADING PLATFORM FOR CELL PROGRAMMING. Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Soaring Eagle Acquisition Corp. ("SRNG" or the "Company") (SRNG) relating to its proposed merger with Ginkgo Bioworks, Inc. FORWARD PURCHASE AGREEMENT . Raaj S. Narayan is a Partner at Wachtell Lipton in the Corporate Department. * Soaring Eagle Acquisition Corp (SRNG) - DEAL VALUES GINKGO ⦠Earlier this year, White & Case LLP advised Soaring Eagle Acquisition Corp. on its US$1.725 billion initial public offering of 172.5 million units, at a price of US$10.00 per unit, including the exercise by the underwriters of their over-allotment option in full. Gross proceeds include Soaring Eagleâs $1.725 billion of cash in trust (subject to any redemptions by Soaring Eagleâs public shareholders) and $775 million in proceeds from a PIPE transaction priced at $10.00 per share of Class A common stock of Soaring Eagle to be funded immediately prior to the closing of the transaction. Adam S. Natan Associate. The terms of the merger value Ginkgo at $15bn on a pre-money basis. $1.5B PIPE. Gross proceeds include Soaring Eagleâs US$1.73 billion of cash in trust (subject to any redemptions by Soaring Eagleâs public shareholders) and US$775 million in proceeds from a PIPE transaction priced at US$10 per share of Class A common stock of Soaring Eagle to be funded immediately prior to the closing of the transaction. It's the 7th SPAC ⦠The transaction is expected to close in the third quarter of 2021. Soaring Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry E. Sloan, Jeff Sagansky, and Eli Baker for the purpose of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Represented Soaring Eagle Distributing, Inc. (AB Distributor) in its sale of assets to D & D Distributors, LLLP d/b/a Grey Eagle Distributors; Represented Wasatch Distributing Co., Inc. (AB Distributor) in its acquisition of the assets of Martyâs Distribution Company, Inc. Soaring Eagle Acquisition Corp (NASDAQ: SRNGU) raised over $1.5 billion in an offering last week. One company, AeroFarms has been revolutionizing the farming industry for 15 years, and today the company is announcing that it is going public via a SPAC merger. Additional Information and Where to Find It Soaring Eagle Acquisition Acquisition Corp (SRNG) has struck a $15B SPAC deal to take cell programming company Ginkgo Bioworks public. Ginkgo is merging with a special purpose acquisition company, or SPAC, called Soaring Eagle Acquisition Corp. News of the deal was first reported ⦠This will include Soaring Eagle's $1.73 billion of cash in trust and $775 million in proceeds from a private investment in public equity, or PIPE, transaction priced at $10.00 per share of Class A common stock of Soaring Eagle, to be funded immediately prior to the closing of the transaction. DISCLAIMER: I'm not a financial advisor. The merger deal is co-sponsored by Eagle Equity Partners alongside Bellco ⦠Earlier this year, White & Case LLP advised Soaring Eagle Acquisition Corp. on its US$1.725 billion initial public offering of 172.5 million units, at a price of US$10.00 per unit, including the exercise by the underwriters of their over-allotment option in full. Subject Company: Ginkgo Bioworks, Inc. Commission File No. Last week Global Corporate Venturing reported various multi-million and multibillion exit transactions across sectors. Business combination with Soaring Eagle Acquisition Corp. (SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds.Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, ⦠Benzinga's " SPACs Attack " covered it all throughout the week. Filed by Soaring Eagle Acquisition Corp. pursuant to . Filed by Soaring Eagle Acquisition Corp. pursuant to . About Soaring Eagle Acquisition Corp. He focuses on mergers and acquisitions, capital markets transactions, takeover and shareholder activism defense and corporate governance matters. So-called PIPE financing is a mechanism for companies to raise capital from a select group of investors that make the final market debut possible. The terms of the merger value Ginkgo at $15bn on a pre-money basis. Soaring Eagle Acquisition Corp (NASDAQ:SRNGU), which is in talks to take Ginkgo Bioworks public, will split its units on Monday April 19. Soaring Eagle Acquisition Corp. is merging with Ginkgo Bioworks Inc. in Boston, to take Ginkgo Bioworks public, and raising $2.5 billion in proceeds for the merged company. Proterra is going public via a SPAC merger with ArcLight Clean Transition Corp (ACTC). The merger deal is co-sponsored by Eagle Equity Partners alongside Bellco Capital, which is ⦠Merger Agreement . Global Eagle Entertainment Inc. offers airline content and connectivity services. Ginkgo Bioworks is in the process of merging with a SPAC called Soaring Eagle Acquisition Corp. (SRNG). The sole purpose of the Blank check companies are to purchase the company, and taking it public and selling in with in couple of years. Soaring Eagle Acquisition Corp., Sloanâs seventh SPAC formation, is led by executives of the same blank-check company that brought DraftKings and Skillz to the public markets last year. While most of that comes from Soaring Eagleâs coffers, about a third has been raised via a $775 million private investment in public equity (PIPE) deal from a range of new and existing investors. David Rosenberg, Co-founder and CEO of AeroFarms, joined Cheddar to discuss. Digital Homeownership Platform Better to Become a Publicly-Listed Company via Merger with Aurora Acquisition Corp.; Company is Redefining the Homeownership Experience. 2) Soaring Eagle Acquisition Corp. (SRNG) & Ginkgo Bioworks The SPAC merger includes an oversubscribed PIPE of $775 million ⦠With the merger, Gingko will go public with $2.5bn in cash proceeds, consisting of $1.7bn from Soaring Eagle Acquisition Corp. and a $775mn PIPE round committed by investors such as Cathie Wood's Ark Invest and Counterpoint Global, an offshoot of Morgan Stanley. 3) Sustainable Opportunities Acquisition Corp. (SOAC) is in talks to merge with DeepGreen Metals, a producer of metals obtained from seafloor deposits for use in electric vehicle batteries, at around a $2.8B valuation, according to Bloomberg. The $2.5 billion in gross proceeds, including $1.725 billion held in trust from Soaring Eagle Acquisition Corp.âs IPO just two months ago, and a $775 million oversubscribed PIPE (private investment in public equity), will be used to scale Ginkgoâs cell programming platform. The $2.5 billion in gross proceeds, including $1.725 billion held in trust from Soaring Eagle Acquisition Corp.âs IPO just two months ago, and a $775 million oversubscribed PIPE (private investment in public equity), will be used to scale Ginkgoâs cell programming platform. Here is a look back at the ⦠When Ginkgo Bioworks merges with Soaring Eagle, the new publicly traded company will be calledGinkgo Bioworks Holdings, Inc. and have a new ticker symbol. The transaction, the latest deal involving a special purpose acquisition company (SPAC) and a gaming firm, values San Francisco-based Skillz at $3.5 billion, or 6.3x 2022 revenue. Each consists of one Class A ordinary share and one-fifth of one warrant to purchase a Class A ordinary share at $11.50. Soaring Eagle Acquisition Corp. Financial Information: Market Cap: $1875.0mil: Revenues: $0 mil (last 12 months) Net Income: $0 mil (last 12 months) IPO Profile: Symbol: SRNGU: Exchange: NASDAQ: Shares (millions): 150.0: Price range: $10.00 - $10.00: Est. Soaring Eagle Acquisition Corp (NASDAQ:SRNGU) raised over $1.5 billion in an offering last week. Soaring Eagle Acquisition Corp (NASDAQ:SRNG) announced a SPAC merger with Ginkgo Bioworks, valuing the company at $15 billion. Gross proceeds include Soaring Eagleâs $1.725 billion of cash in trust (subject to any redemptions by Soaring Eagleâs public shareholders) and $775 million in proceeds from a PIPE transaction priced at $10.00 per share of Class A common stock of Soaring Eagle to be funded immediately prior to the closing of the transaction.
Stretch And Challenge Activities Science,
Northern Ireland Lockdown 2020,
Menomonee Falls Baseball,
Floryday Long Cardigan,
Power Wheels Thomas Track Extension,
Chelsea Spending 2020,